Kailera Therapeutics to Participate in November Investor Conferences
Key Highlights
- ➤Kailera (KLRA) management to participate in three November investor conferences
- ➤Stifel presentation scheduled for November 10, 2026, at 4:00 pm ET
- ➤Jefferies fireside chat scheduled for November 16, 2026, at 10:00 am GMT
- ➤Evercore fireside chat scheduled for December 2, 2026, at 8:45 am ET
- ➤Ribupatide injection is in global Phase 3 trials as a once-weekly GLP-1/GIP agonist
Expert Statements
Ron Renaud, President and Chief Executive Officer of Kailera Therapeutics
“Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care”
WALTHAM, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (Nasdaq: KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced that Ron Renaud, President and Chief Executive Officer, and additional members of the management team will participate in the following investor conferences: * Stifel 2026 Healthcare Conference November 10-12, 2026, New York, NY Presentation: Tuesday, November 10, 2026, at 4:00 pm ET
* Jefferies Global Healthcare Conference in London November 16-19, 2026, London, UK Fireside Chat: Monday, November 16, 2026, at 10:00 am GMT
Get started
Create a free account to read the full story.